The purpose of the proposed research is to continue the molecular characterization of the feline immunodeficiency virus (FIV) genome. The overall goal of the study is to understand the role of each viral protein in the virus life cycle and to develop the feline/FIV model as a vehicle for design of treatments against lentivirus infections.
The Specific Aims of the proposal are to 1) characterize the molecular interactions involved in receptor binding by FIV, both the binding to the chemokine receptor, CxCR4 as well as the identification and characterization of a putative second receptor. These studies will also include the characterization and mapping of monoclonal antibodies that we have generated that block CxCR4 binding to the surface glycoprotein and those that facilitate neutralization of the virus; 2) continue the characterization of the transactivator protein, Orf2, with emphasis on identification of interaction partners and definition of residues critical to Orf 2 function ; and 3) continue the molecular analysis of FIV Vif, including mutagenesis studies to define residues critical to Vif function. We will also attempt to identify Vif interaction partners and search for permissive cat cells that allow production of competent FIV in the absence of functional FIV, similar to cells identified as permissive and non-permissive for HIV Vif. The studies outlined will advance our knowledge of the FIV life cycle and further refine the model for use in the development of drug and vaccine-based intervention strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI025825-19
Application #
6858570
Study Section
Special Emphasis Panel (ZRG1-AARR-1 (01))
Program Officer
Miller, Roger H
Project Start
1987-09-30
Project End
2006-12-14
Budget Start
2005-04-01
Budget End
2006-12-14
Support Year
19
Fiscal Year
2005
Total Cost
$398,925
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Hu, Qiong-Ying; Fink, Elizabeth; Grant, Chris K et al. (2014) Selective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virus. PLoS One 9:e115252
Troyer, Ryan M; Thompson, Jesse; Elder, John H et al. (2013) Accessory genes confer a high replication rate to virulent feline immunodeficiency virus. J Virol 87:7940-51
Wood, Britta A; Carver, Scott; Troyer, Ryan M et al. (2013) Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infection. J Immunol Methods 396:74-86
Hu, Qiong-Ying; Fink, Elizabeth; Elder, John H (2012) Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection. Retrovirology (Auckl) 2012:1-11
Breuer, Sebastian; Sepulveda, Homero; Chen, Yu et al. (2011) A cleavage enzyme-cytometric bead array provides biochemical profiling of resistance mutations in HIV-1 Gag and protease. Biochemistry 50:4371-81
Miller, Craig; Bielefeldt-Ohmann, Helle; MacMillan, Martha et al. (2011) Strain-specific viral distribution and neuropathology of feline immunodeficiency virus. Vet Immunol Immunopathol 143:282-91
Thompson, Jesse; MacMillan, Martha; Boegler, Karen et al. (2011) Pathogenicity and rapid growth kinetics of feline immunodeficiency virus are linked to 3' elements. PLoS One 6:e24020
Hu, Qiong-Ying; Fink, Elizabeth; Happer, Meaghan et al. (2011) Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein. J Virol 85:7108-17
Hu, Qiong-Ying; Fink, Elizabeth; Hong, Yang et al. (2010) Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein. PLoS One 5:e10689
Elder, John H; Lin, Ying-Chuan; Fink, Elizabeth et al. (2010) Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. Curr HIV Res 8:73-80

Showing the most recent 10 out of 48 publications